Dermata Therapeutics, Inc. SEC filings DRMA
Dermata Therapeutics, Inc. has 371 filings in SEC EDGAR's recent list, going back to Apr 2, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 7, 2026 | Apr 6, 2026 |
| DEFA14A | Additional proxy material | Jun 2, 2025 | — |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 2, 2025 |
| PRE 14A | Preliminary proxy statement | May 23, 2025 | May 23, 2025 |
| DEFA14A | Additional proxy material | Mar 26, 2024 | — |
| DEF 14A | Proxy statement | Mar 26, 2024 | Mar 5, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 4, 2024 | Feb 28, 2024 |
| DEF 14A | Proxy statement | Dec 8, 2023 | Dec 7, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 29, 2023 | Nov 28, 2023 |
| DEFA14A | Additional proxy material | Jul 12, 2023 | — |
| DEFA14A | Additional proxy material | Jun 23, 2023 | — |
| DEF 14A | Proxy statement | Jun 23, 2023 | Aug 3, 2023 |
| DEF 14A | Proxy statement | Jan 13, 2023 | Jan 11, 2023 |
| PRE 14A | Preliminary proxy statement | Jan 3, 2023 | Jan 3, 2023 |
| DEFA14A | Additional proxy material | Jun 1, 2022 | — |
| DEF 14A | Proxy statement | Jun 1, 2022 | Jul 11, 2022 |
| PRE 14A | Preliminary proxy statement | May 20, 2022 | May 20, 2022 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DRMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1853816
- Former names
- Dermata Therapeutics, Inc. (until Nov 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.